In addition, silmitasertib induces apoptosis in epidermoid carcinoma and squamous carcinoma cells by a complete inhibition of the PI3K/Akt/mTOR pathway in combination with erlotinib28. Here, PIK3CA is linked to squamous cell carcinoma.